SG11201708068PA - Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof - Google Patents

Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof

Info

Publication number
SG11201708068PA
SG11201708068PA SG11201708068PA SG11201708068PA SG11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA SG 11201708068P A SG11201708068P A SG 11201708068PA
Authority
SG
Singapore
Prior art keywords
methods
active agent
extended release
injectable formulations
isoxazoline active
Prior art date
Application number
SG11201708068PA
Inventor
Susan Mancini Cady
Peter Cheifetz
Izabela Galeska
Fallois Loic Le Hir De
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of SG11201708068PA publication Critical patent/SG11201708068PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SG11201708068PA 2015-04-08 2016-04-06 Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof SG11201708068PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562144871P 2015-04-08 2015-04-08
PCT/US2016/026253 WO2016164487A1 (en) 2015-04-08 2016-04-06 Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof

Publications (1)

Publication Number Publication Date
SG11201708068PA true SG11201708068PA (en) 2017-10-30

Family

ID=57072717

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201708068PA SG11201708068PA (en) 2015-04-08 2016-04-06 Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
SG10201912724SA SG10201912724SA (en) 2015-04-08 2016-04-06 Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201912724SA SG10201912724SA (en) 2015-04-08 2016-04-06 Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof

Country Status (18)

Country Link
US (2) US20170020848A1 (en)
EP (1) EP3280413A1 (en)
JP (2) JP6824900B2 (en)
KR (1) KR102593069B1 (en)
CN (1) CN108055825B (en)
AR (1) AR104212A1 (en)
AU (3) AU2016246598B2 (en)
BR (1) BR112017021073A2 (en)
CA (1) CA2981797C (en)
CL (1) CL2017002536A1 (en)
CO (1) CO2017010065A2 (en)
EA (2) EA202090762A1 (en)
IL (1) IL254813B (en)
MX (2) MX2017012848A (en)
NZ (1) NZ736374A (en)
SG (2) SG11201708068PA (en)
UY (1) UY36610A (en)
WO (1) WO2016164487A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY37137A (en) * 2016-02-24 2017-09-29 Merial Inc ANTIPARASITARY COMPOUNDS OF ISOXAZOLINE, INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE THEM, METHODS AND USES OF THE SAME
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
US10662163B2 (en) * 2017-04-05 2020-05-26 Boehringer Ingelheim Animal Health USA Inc. Crystalline forms of (S)-afoxolaner
PL3609470T3 (en) 2017-04-13 2024-04-15 Ceva Santé Animale Implant for treating parasites infestations
US20210177808A1 (en) 2017-11-07 2021-06-17 Intervet Inc. Injectable isoxazoline pharmaceutical compositions and their use against parasite infestation
UA127892C2 (en) 2017-11-07 2024-02-07 Інтервет Інтернешнл Б.В. Process for preparing large size isoxazoline particles
AU2018385363A1 (en) * 2017-12-12 2020-05-14 Intervet International B.V. Implantable isoxazoline pharmaceutical compositions and uses thereof
TWI812673B (en) 2018-02-12 2023-08-21 美商富曼西公司 Naphthalene isoxazoline compounds for controlling invertebrate pests
AU2020268618A1 (en) 2019-05-03 2021-11-04 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
AU2021277491A1 (en) * 2020-05-20 2022-12-01 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
IL309666A (en) 2021-07-09 2024-02-01 Plexium Inc Aryl compounds and pharmaceutical compositions that modulate ikzf2

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3740421A (en) 1966-09-19 1973-06-19 Basf Wyandotte Corp Polyoxyethylene-polyoxypropylene aqueous gels
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
JPS4914624A (en) 1972-06-08 1974-02-08
SE434277B (en) 1976-04-19 1984-07-16 Merck & Co Inc SET TO MAKE NEW ANTIHELMINTICALLY EFFECTIVE ASSOCIATIONS BY CULTIVATING STREPTOMYCS AVERMITILIS
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4203976A (en) 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
JPS57139012A (en) 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
DE3681465D1 (en) 1985-02-04 1991-10-24 Nihon Bayer Agrochem K.K., Tokio/Tokyo, Jp
EP0237482A1 (en) 1986-03-06 1987-09-16 Ciba-Geigy Ag Derivatives of C(29)-carbonyloxy-milbemycine against parasites in animals and plants
DE3785936T2 (en) 1986-03-25 1993-08-26 Sankyo Co MACROLIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE.
ES2039258T3 (en) 1986-07-02 1993-09-16 Ciba-Geigy Ag PESTICIDES.
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
DE3888936T2 (en) 1987-11-03 1994-07-21 Beecham Group Plc Intermediates for the production of macrolide antibiotics with an anthelmintic effect.
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
NZ247278A (en) 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
US5330768A (en) 1991-07-05 1994-07-19 Massachusetts Institute Of Technology Controlled drug delivery using polymer/pluronic blends
US5345377A (en) 1992-10-30 1994-09-06 Electric Power Research Institute, Inc. Harmonic controller for an active power line conditioner
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
ES2359973T3 (en) * 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES.
CN102558082B (en) 2004-03-05 2015-09-30 日产化学工业株式会社 Isoxazoline-substituted benzamide compound prepare intermediate
US8362086B2 (en) 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
EP1932836B1 (en) 2005-09-02 2013-11-06 Nissan Chemical Industries, Ltd. Isoxazoline-substituted benzamide compound and harmful organism-controlling agent
US20090143410A1 (en) 2005-12-14 2009-06-04 Kanu Maganbhai Patel Isoxazolines for Controlling Invertebrate Pests
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (en) 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
BRPI0710403A2 (en) 2006-04-20 2011-08-09 Du Pont compound composition, control composition, spraying, bait, trap device, control methods, protection methods, treated seed, protective composition
JP2008044880A (en) 2006-08-15 2008-02-28 Bayer Cropscience Ag Insecticidal isooxazolines
JP5256753B2 (en) 2007-03-29 2013-08-07 住友化学株式会社 Isoxazoline compounds and their pest control applications
US8372867B2 (en) 2007-04-10 2013-02-12 Bayer Cropscience Ag Insecticidal aryl isoxazoline derivatives
MX2009013469A (en) 2007-06-13 2010-01-20 Du Pont Isoxazoline insecticides.
TWI430995B (en) 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
TWI556741B (en) 2007-08-17 2016-11-11 英特威特國際股份有限公司 Isoxazoline compositions and their use as antiparasitics
CN101809004B (en) 2007-10-03 2012-12-26 杜邦公司 Naphthalene isoxazoline compounds for control of invertebrate pests
ES2635120T3 (en) 2008-07-09 2017-10-02 Basf Se Active pesticide mixtures comprising isoxazoline compounds I
EP2379544B1 (en) * 2008-12-18 2013-10-16 Novartis AG Isoxazolines derivatives and their use as pesticide
ME03475B (en) * 2009-12-17 2020-01-20 Merial Inc Antiparasitic dihydroazole compositions
KR20130124458A (en) * 2010-05-27 2013-11-14 이 아이 듀폰 디 네모아 앤드 캄파니 Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-0x0-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide
DK178277B1 (en) * 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazoline compounds for the control of fish lice
CN103260620A (en) 2010-12-27 2013-08-21 英特维特国际股份有限公司 Topical localized isoxazoline formulation comprising glycofurol
JP2014505089A (en) * 2011-02-10 2014-02-27 ノバルティス アーゲー Isoxazoline derivatives for controlling invertebrate pests
CN103517907B (en) 2011-03-10 2016-07-06 硕腾服务有限责任公司 Volution isoxazolines derivative as antiparasitic
AR085657A1 (en) * 2011-03-10 2013-10-16 Novartis Ag ISOXAZOL COMPOUNDS
RS61048B1 (en) * 2011-09-12 2020-12-31 Boehringer Ingelheim Animal Health Usa Inc Parasiticidal compositions comprising an isoxazoline active agent, method and uses thereof
AR088668A1 (en) * 2011-11-21 2014-06-25 Lilly Co Eli SMALL MOLECULES CONTAINING BORO
AR088669A1 (en) * 2011-11-21 2014-06-25 Lilly Co Eli DERIVATIVES OF DIHYDRODIBENZO [C] [1,2] OXABOROL AND DIHYDROISOXAZOL USEFUL FOR THE CONTROL OF ECTOPARASITES
HUE036441T2 (en) * 2011-12-02 2018-07-30 Merial Inc Long-acting injectable moxidectin formulations and novel moxidectin crystal forms
MY167560A (en) 2012-02-06 2018-09-14 Merial Inc Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
AU2013312891A1 (en) 2012-09-07 2015-02-26 Zoetis Services Llc Spirocyclic isoxazolines as antiparasitic agents
BR112015004698B8 (en) * 2012-09-07 2022-11-22 Zoetis Llc SYNERGIC PARASITIDAL COMPOSITIONS AND THEIR USES
EP2999339B1 (en) 2013-05-20 2019-06-19 Zoetis Services LLC Long-acting spiro-isoxazoline antiparasitic compositions
US10350196B2 (en) * 2013-09-30 2019-07-16 Zoetis Services Llc Long-acting spiro-isoxazoline formulations

Also Published As

Publication number Publication date
CN108055825B (en) 2021-03-30
EP3280413A1 (en) 2018-02-14
AU2016246598B2 (en) 2020-07-23
KR20170134700A (en) 2017-12-06
AU2020210266A1 (en) 2020-08-20
US20170020848A1 (en) 2017-01-26
AU2020210266B2 (en) 2022-03-10
JP2021050206A (en) 2021-04-01
NZ736374A (en) 2024-02-23
IL254813B (en) 2020-03-31
CA2981797A1 (en) 2016-10-13
EA201792235A1 (en) 2018-01-31
MX2022010831A (en) 2022-09-29
UY36610A (en) 2016-10-31
EA202090762A1 (en) 2020-09-08
SG10201912724SA (en) 2020-02-27
CA2981797C (en) 2023-11-21
CN108055825A (en) 2018-05-18
AR104212A1 (en) 2017-07-05
MX2017012848A (en) 2018-01-15
AU2016246598A1 (en) 2017-11-02
EA036272B1 (en) 2020-10-21
CO2017010065A2 (en) 2018-01-05
KR102593069B1 (en) 2023-10-23
BR112017021073A2 (en) 2018-07-03
JP2018510897A (en) 2018-04-19
US20210299104A1 (en) 2021-09-30
CL2017002536A1 (en) 2018-04-20
AU2022202035A1 (en) 2022-04-14
JP6824900B2 (en) 2021-02-03
WO2016164487A1 (en) 2016-10-13
IL254813A0 (en) 2017-12-31

Similar Documents

Publication Publication Date Title
IL254813B (en) Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
ZA201805476B (en) Antiparasitic isoxazoline compounds, long¿acting injectable formulations comprising them, methods and uses thereof
IL249370A0 (en) Fap-activated therapeutic agents, and uses related thereto
HK1251183A1 (en) Bioconjugates and uses thereof
GB201512203D0 (en) Agents,uses and methods
SG11201705034RA (en) Copolymer and oily gelling agent
HK1256674A1 (en) Deuterium-modified brigatinib derivatives, pharmaceutical compositions comprising same, and use thereof
PL3232780T3 (en) Aqueous electrolyte-containing adjuvant compositions, active ingredient-containing compositions and the use thereof
SG11201803669UA (en) Microorganism-controlling agent and miticidal composition
HK1259291A1 (en) Game device, game system, and program
IL248586B (en) Optically active pde10 inhibitor, compositions comprising same, proceses for preparing same and uses thereof
GB201512215D0 (en) Agents,uses and methods
PT3011831T (en) Limonene: formulation and insecticide use
PL3307275T3 (en) Injectable antibiotic formulations and use thereof
HK1251924A1 (en) Foxm1-derived peptide, and vaccine including same
PL3253857T3 (en) Aqueous formulations, their manufacture and use
IL246606A0 (en) Mir-122 as an active micro-rna, compositions comprising the same and uses thereof
PL3072529T3 (en) Composition comprising vemurafenib and hpmc-as
SG11201700122TA (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
HK1251928A1 (en) Mphosph1-derived peptide, and vaccine including same
ZA201708307B (en) Improved herbicidal composition, method and use
GB201718394D0 (en) Some alcohol ethoxyles, their application and use
HUE052947T2 (en) Immunity-inducing agent
GB201518375D0 (en) Agents,uses and methods
GB201512211D0 (en) Agents, uses and methods